Peregrine Pharma (PPHM) Posts Mixed Q4 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
Tweet
Share
E-mailGet Alerts PPHM Hot Sheet
Price: $0.61 --0%
Financial Fact:
Contract manufacturing revenue: 5.61M
Today's EPS Names:
TMQ, OMH, AEHR, More
Financial Fact:
Contract manufacturing revenue: 5.61M
Today's EPS Names:
TMQ, OMH, AEHR, More
Join SI Premium – FREE
Peregrine Pharma (NASDAQ: PPHM) reported Q4 EPS of ($0.05), $0.02 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $18.78 million versus the consensus estimate of $15.8 million.
Peregrine reported $61,412,000 in cash and cash equivalents as of April 30, 2016, compared to $68,001,000 at fiscal year ended April 30, 2015.
For earnings history and earnings-related data on Peregrine Pharma (PPHM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX (SPCX) PT Raised to $230 at Goldman Sachs ahead of earnings release
- Alethia Capital Starts TTM Technologies (TTMI) at Overweight, 'A Unique Proxy Standing for USA PCB'
- Allegion acquires specialty door maker Overly Door Company
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
